Drawing for PROVEPHARM

USPTO serial 79275168

PROVEPHARM

Reviewed by CopyMark Law Group

Reg. 6150137Status 708Renewal
Filing date
Status date
Registration date
Sep 15, 2020
Examiner
MCCLELLAN, MATTHEW D.
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with PROVEPHARM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $425

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Aaron Y. Silverstein

Aaron Y. Silverstein Saunders & Silverstein LLP14 Cedar Street, Suite 224Amesbury, MA 01913-1831United States

Goods and services

ClassDescriptionStatusFirst use
001[ Chemical products in the nature of bulk powders, chemical intermediate for the synthesis of pharmaceutical active substances for use in industry, in science; Chemical preparations in the nature of methylene blue for scientific or research use; chemical products for use in manufacture of medicines; raw proteins for scientific and medical research; proteins used in manufacturing processes; chemical products, emulsifiers, vitamins, antioxidants, additives, emollients and proteins for manufacture of cosmetics ]SECTION 71 - CANCELLED—
005Pharmaceutical and sanitary products and preparations for medical purposes, for human and animal health; chemical preparations in the nature of methylene blue for medical use; chemical preparations in the nature of methylene blue solutions for medical use; [ medicines for the treatment of blood poisoning; ] Medicines used as a contrast solution for scintigraphic imaging procedures; medicines for medical diagnostic purposes for viewing and marking tissue; medicines for the detection of fistulas and leaks during surgical procedures; medicines for tissue staining; medicines for the detection of the sentinel lymph node; medicines for conducting visceral surgery; clinical medical reagents [ ; Synthetic peptides for pharmaceutical use, namely, for cancer treatments, immunotherapy, cell therapy, antivirals and antibiotics; medicines for animals; vitamins for animals; foams, oils, lotions, creams, balms, lotions, ointments, gels and milks for pharmaceutical, medical or veterinary use; phytotherapy preparations for medical use ]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 14, 2026NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Sep 14, 2026C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
Sep 7, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 9, 2026ES75TEAS SECTION 71 & 15 RECEIVED—
Sep 15, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 23, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 31, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 31, 2020FIMPFINAL DISPOSITION PROCESSED—
Dec 15, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 15, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 30, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 30, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 10, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 26, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 25, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 25, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 25, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 10, 2020RFNTREFUSAL PROCESSED BY IB—
Mar 25, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 25, 2020RFRRREFUSAL PROCESSED BY MPU—
Mar 6, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 5, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2020RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Feb 12, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 11, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 4, 2020DOCKASSIGNED TO EXAMINER—
Jan 10, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 6, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 26, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance